Oncotarget Microbial Metabolite Mimicry May Improve Drug Discovery
Jan 17, 2022
Dr. Sridhar Mani, a researcher from The Albert Einstein College of Medicine, discusses the use of microbial metabolite mimicry in drug discovery. Topics include the role of bacterial metabolites, designing molecules to mimic metabolite bindings, and enhancing drug efficacy with cost-effective synthesis. The podcast explores a novel approach to developing therapeutics with long-term efficacy and reduced side effects.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 3min
Exploring Microbial Metabolite Mimicry in Drug Discovery
02:32 • 3min
Exploring Microbial Metabolite Mimicry for Drug Discovery
05:12 • 2min
Microbial Metabolite Mimicry in Drug Discovery
07:27 • 6min
Innovative Approach to Drug Development Through Metabolite Mimicry and Selective Advantage
13:54 • 3min